Long-Term Antibody Persistence at 1, 3 and 5 Years After a Booster Dose of GSKBiologicals Hib-MenCY-TT Vaccine Compared to ActHIB

This study is ongoing, but not recruiting participants.

Study NCT00359983 Information provided by GlaxoSmithKline

First Received: July 31, 2006 Last Updated: September 2, 2008 History of Changes

No Study Results Posted for this Study

Study Status:	This study is ongoing, but not recruiting participants.
Estimated Study Completion Date:	No date given
Estimated Primary Completion Date:	November 2011 (Final data collection date for primary outcome measure)